In the MetS subgroup, the patients were stratified according to gender, TNM stage, tumor differentiation, HDL (<1.2 vs. ≥ 1.2 mmol/dl), and CEA (<5 vs. ≥ 5 ng/ml), respectively (Figure 3). This evidence concerns the gene CEACAM5 and neoplasm.